LAS VEGAS -- Skinvisible, Inc. announces that it has signed a distribution agreement with Canadian-based Clara Laboratories Ltd. granting them the right to distribute, market and sell its patented Antimicrobial Hand Sanitizer lotion and spray formulation through established sub-distributors in China, Singapore, Hong Kong and Macau.
Skinvisible has shipped an initial order of 19 55-gallon drums of the Antimicrobial Hand Sanitizer formulation for the Honk Kong market. Skinvisible expects to ship product both in bulk drums and pre-packaged in order to meet a strong and growing demand for its proprietary formulation within the Asian marketplace. Clara Laboratories has a mandate to represent and promote North American medical technologies within the Asian marketplace and reciprocally represent Asian technologies within North America.
Proven advantages of the Skinvisible formulation include its demonstrated ability to adhere to the skin, forming a protective bond, resisting both wash-off and perspiration while holding the active ingredient Triclosan on the skin for extended periods of time. Independent studies show that the active agent stays on the skin for up to 4 hours per application, maintaining its effectiveness even with frequent hand washings, providing a continuous kill of pathogens tested during that time. Skinvisible's proprietary formulation is alcohol-free, offering distinct advantages over alcohol-based gel sanitizers that typically provide instant protection but offer no long-term persistence, wash-off, and require continuous reapplication, sometimes causing adverse skin reactions.
"Although it is proven to be effective on its own, we specifically designed our sanitizer formulation to be a complementary adjunct to hand washing rather than a replacement," emphasizes Skinvisible's chemist, Dr. James Roszell. "What sets our product apart is not only its ability to bond to the skin and remain effective for extended periods, but also the simultaneous benefit of protecting the skin against the rigors of even frequent hand-washing such as that required to meet medical and food service protocols."
Source: Skinvisible, Inc.
The Key to Sterile Processing Success: Leadership Engagement and Team Collaboration
January 24th 2025Effective sterile processing leadership requires active engagement, clear communication, and a transformational approach to foster collaboration, accountability, and quality in infection prevention and surgical instrument management.
Evaluating Automated Dispensing Systems for Disinfectants in Hospitals
January 23rd 2025Hospitals rely on automated disinfectant dispensers, but a study led by Curtis Donskey, MD, found inconsistent dilution levels, with some dispensers releasing only water. Improved monitoring and design modifications are essential.
Alcohol-Based Antiseptics Show Promise for Nasal Decolonization and SSI Prevention
January 23rd 2025A meta-analysis found alcohol-based antiseptics significantly reduce Staphylococcus aureus-related surgical site infections (SSIs), demonstrating efficacy comparable to mupirocin and iodophor, supporting their expanded use in infection prevention strategies.
ASRA Pain Medicine Releases Groundbreaking Infection Control Guidelines for Pain Management
January 22nd 2025The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) released comprehensive infection control guidelines for pain procedures, emphasizing prevention, early recognition, multidisciplinary collaboration, and judicious antibiotic use to enhance patient safety and healthcare outcomes.